Independent scientific reviews
The evidence regarding the efficacy and safety of Nerivio have been examined by several impartial scientific reviews and meta-analysis.
Results:
- Systematic meta-analysis review of neuromodulation devices for migraine.
Moisset et al., 2020
"The only neurostimulation device with sufficient evidence-based research supporting efficacy for acute migraine treatment."
Source: Moisset X, Pereira B, Ciampi de Andrade D, Fontaine D, Lantéri-Minet M, Mawet J. Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2020;21(1):142. doi:10.1186/s10194-020-01204-4 - Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults
VanderPluym et al., June 2021, JAMA
"The only neurostimulation device with moderate strength of evidence (SOE)."
Source: VanderPluym JH, Halker Singh RB, Urtecho M, et al. Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis. JAMA. 2021;325(23):2357-2369. doi:10.1001/jama.2021.7939 - Latest guidelines of the French Headache Society for treating migraine
Demarquay et al., July 2021
"The only neurostimulation device with moderate strength of evidence (SOE) by the French Headache Society."
Source: Demarquay G, Mawet J, Guégan-Massardier E, et al. Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment. Rev Neurol (Paris). 2021;177(7):753-759. doi:10.1016/j.neurol.2021.07.009
